Radiobiological considerations in magna-field irradiation.
Radiobiological considerations are described for total body irradiation (TBI) as given to patients undergoing bone marrow transplantation (BMT). Although much progress has been made in the use of BMT for refractory leukemias, many patients still die from interstitial pneumonia and relapse. Fractionated TBI has been introduced in order to improve leukemic cell kill, while increasing the degree of normal tissue tolerance. Traditionally, bone marrow stem cells, leukemic cells and immunocytes have been considered as having a limited ability to repair radiation damage while cells of lung tissue and intestinal epithelial cells have a greater capacity. During fractionated radiation therapy or continuous low-dose rate exposure, repair of sublethal damage between fractions allows greater recovery in the cell of lung tissue compared to those in the bone marrow. Clinically, the potential benefit of six fractions over one fraction or low dose-rate TBI has yet to be proved, although there is suggestive evidence for a reduced incidence of interstitial pneumonitis. However, other extraneous factors such as doses to the lung, differences in conditioning regimens, effect of increased delay in BMT for patients receiving fractionated TBI, and the unmeasurable differences between insitutions make definite conclusions impossible. Despite this, a consenus for dose fractionation has developed and most centers are moving away from the use of large single dose TBI.
Evans
R G
RG
Fricke Radiobiology Laboratories, Mayo Clinic and Foundation, Rochester, MN 55901, USA.
D000818:Animals; D016026:Bone Marrow Transplantation; D002455:Cell Division / Q000187:drug effects; D006224:Cricetinae; D019583:Dose Fractionation, Radiation; D004307:Dose-Response Relationship, Radiation; D006412:Hematopoietic Stem Cells; D006801:Humans; D008168:Lung / Q000528:radiation effects; D051379:Mice; D011832:Radiation Injuries / Q000209:etiology / Q000517:prevention & control; D017564:Radiation Pneumonitis / Q000209:etiology / Q000517:prevention & control; D011853:Radiobiology; D019172:Transplantation Conditioning; D014916:Whole-Body Irradiation / Q000009:adverse effects / Q000379:methods*